79 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
® within the global pediatric cancer community,” said Rosty Raykov, Chief Executive Officer of Fennec. “PEDMARK® is the only approved therapy
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
representing 96% quarter over quarter growth. PEDMARK® addresses a significant unmet medical need in the pediatric oncology community, and we expect
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
6 Jun 23
Other Events
5:39pm
We look forward to making this important treatment available to the pediatric oncology community in the EU as soon as possible.”
The European
8-K
EX-99.1
kdto0itq
4 Apr 23
Other Events
12:32pm
8-K
EX-99.1
qaerv 8fyvx8jdbe1f
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm
8-K
EX-99.1
31c z7keluvy3
24 Jun 21
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
12:02pm
424B5
3p3p08jy 8zftnu2zmc9
30 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
EX-99.1
a507xu19zkr0sbcqrzg5
26 Jun 20
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
4:13pm